Position in PFE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$220,393,187
-$215,099,504 QoQ
Shares Held
9,152,541
-41.0% QoQ
Ownership
0.161%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#62
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VICTORY CAPITAL MANAGEMENT INC holds $5,636,745,309 across 13 Drug Manufacturers - General names. PFE ranks #8 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,141,447 | $2,568,515,989 | |
| 2 | JNJ |
Johnson & Johnson
|
2,620,929 | $665,637,338 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
10,168,924 | $585,933,400 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,143,885 | $532,489,222 | |
| 5 | ABBV |
AbbVie Inc.
|
1,581,740 | $398,029,053 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,203,012 | $278,328,536 | |
| 7 | AMGN |
Amgen Inc
|
632,302 | $228,969,200 | |
| 8 | PFE |
Pfizer Inc
This page
|
9,152,541 | $220,393,187 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $220,393,187 | 9,152,541 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $435,492,691 | 15,508,999 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $492,929,488 | 19,796,365 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $412,438,415 | 16,186,751 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $366,396,493 | 15,115,367 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $119,465,835 | 4,714,516 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $136,705,402 | 5,152,861 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $100,904,287 | 3,486,672 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $121,519,574 | 4,343,087 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $119,694,102 | 4,313,301 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $146,018,647 | 5,071,853 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $149,897,717 | 4,519,075 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $165,892,195 | 4,522,688 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $213,440,956 | 5,231,396 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $229,834,355 | 4,485,448 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $218,092,619 | 4,983,835 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $246,298,785 | 4,697,669 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $229,780,627 | 4,438,490 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $223,367,254 | 3,782,680 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $162,791,301 | 3,784,964 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $162,604,616 | 4,152,314 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $162,046,899 | 4,472,727 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $176,750,650 | 4,801,702 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $191,902,642 | 5,228,960 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $162,937,826 | 4,982,803 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $154,897,773 | 4,745,649 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||